Literature DB >> 1593277

alpha-Tocopherol treatment for tardive dyskinesia.

B Spivak1, B Schwartz, M Radwan, A Weizman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1593277     DOI： 10.1097/00005053-199206000-00012

Source DB:  PubMed          Journal:  J Nerv Ment Dis        ISSN： 0022-3018            Impact factor:   2.254


× No keyword cloud information.
  4 in total

Review 1.  Oxidative mechanisms and tardive dyskinesia.

Authors:  James B Lohr; Ronald Kuczenski; Alexander B Niculescu
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

2.  Combined treatment of ascorbic acid or alpha-tocopherol with dopamine receptor antagonist or nitric oxide synthase inhibitor potentiates cataleptic effect in mice.

Authors:  M Lazzarini; C Salum; E A Del Bel
Journal:  Psychopharmacology (Berl)       Date:  2005-10-15       Impact factor: 4.530

3.  Vitamin E attenuates the development of haloperidol-induced dopaminergic hypersensitivity in rats: possible implications for tardive dyskinesia.

Authors:  W F Gattaz; A Emrich; S Behrens
Journal:  J Neural Transm Gen Sect       Date:  1993

Review 4.  Vitamin E for antipsychotic-induced tardive dyskinesia.

Authors:  Karla Soares-Weiser; Nicola Maayan; Hanna Bergman
Journal:  Cochrane Database Syst Rev       Date:  2018-01-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.